People · Operator
Named in public records as an officer, director or promoter · active 2012–2023 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Photopharmics Inc | — | Other Technology | Series B | $44.8M | $247.7M | 2012 |
| EpiVax Therapeutics, Inc. | — | Biotechnology | Seed | $2.6M | $14.8M | 2019 |
| Earthineer, LLC | — | Other Technology | Pre-Seed | $438K | $7.9M | 2013 |
| New England Network Solutions, LLC | — | Other Technology | Pre-Seed | $359K | $10.6M | 2021 |
Daniel Adams at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Adams on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gavin Christensen | 1 | 23 |
| William Martin | 1 | 3 |
| Richard Lipkin | 1 | 2 |
| Kent Savage | 1 | 2 |
| Gad Berdugo | 1 | 2 |
| Henry, Jr. C. Savage | 1 | 1 |
| Michael Kourkoulakos | 1 | 1 |
| Clifford Grimm | 1 | 1 |
| Anne De Groot | 1 | 1 |
| Joshua Oakes | 1 | 1 |
| Henry, Jr. Savage | 1 | 1 |
| Ted Stanley | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.